Non-ABO red cell antibodies and risk of COVID-19.
ABO blood group
COVD-19
Non-ABO blood group antibodies
SARS-CoV-2
Journal
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
ISSN: 1878-3511
Titre abrégé: Int J Infect Dis
Pays: Canada
ID NLM: 9610933
Informations de publication
Date de publication:
Jul 2021
Jul 2021
Historique:
received:
21
04
2021
revised:
11
05
2021
accepted:
16
05
2021
pubmed:
23
5
2021
medline:
20
8
2021
entrez:
22
5
2021
Statut:
ppublish
Résumé
It is not known whether non-ABO antibodies confer any protective effect against SARS-CoV-2 infection or COVID-19 severe illness alone or in conjunction with O blood group. This cohort study included 413 576 persons in Ontario, Canada with known ABO blood group and non-ABO antibody screen status, who subsequently underwent SARS-CoV-2 viral RNA polymerase chain reaction testing between January and November 2020. The risk of SARS-CoV-2 infection or COVID-19 severe illness was not associated with the presence of non-ABO antibodies, even among persons with O blood group.
Identifiants
pubmed: 34022334
pii: S1201-9712(21)00440-9
doi: 10.1016/j.ijid.2021.05.038
pmc: PMC8132504
pii:
doi:
Substances chimiques
ABO Blood-Group System
0
Antibodies, Viral
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
179-182Informations de copyright
Copyright © 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved.